BOK Financial’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,692
| Closed | -$218K | – | 909 |
|
|
2022
Q1 | $218K | Sell |
8,692
-625
| -7% | -$15.7K | ﹤0.01% | 906 |
|
|
2021
Q4 | $334K | Sell |
9,317
-8
| -0.1% | -$287 | 0.01% | 800 |
|
|
2021
Q3 | $397K | Buy |
+9,325
| New | +$397K | 0.01% | 758 |
|
|
2021
Q1 | $392K | Hold |
9,608
| – | – | 0.01% | 737 |
|
|
2020
Q4 | $435K | Sell |
9,608
-277
| -3% | -$12.5K | 0.01% | 694 |
|
|
2020
Q3 | $350K | Sell |
9,885
-288
| -3% | -$10.2K | 0.01% | 693 |
|
|
2020
Q2 | $384K | Buy |
10,173
+243
| +2% | +$9.17K | 0.01% | 690 |
|
|
2020
Q1 | $287K | Sell |
9,930
-916
| -8% | -$26.5K | 0.01% | 703 |
|
|
2019
Q4 | $562K | Sell |
10,846
-191
| -2% | -$9.9K | 0.01% | 676 |
|
|
2019
Q3 | $606K | Sell |
11,037
-1,965
| -15% | -$108K | 0.01% | 623 |
|
|
2019
Q2 | $528K | Sell |
13,002
-1,914
| -13% | -$77.7K | 0.01% | 657 |
|
|
2019
Q1 | $451K | Hold |
14,916
| – | – | 0.01% | 701 |
|
|
2018
Q4 | $501K | Buy |
14,916
+3,511
| +31% | +$118K | 0.01% | 617 |
|
|
2018
Q3 | $481K | Buy |
11,405
+281
| +3% | +$11.9K | 0.01% | 688 |
|
|
2018
Q2 | $356K | Sell |
11,124
-11
| -0.1% | -$352 | 0.01% | 758 |
|
|
2018
Q1 | $554K | Buy |
11,135
+270
| +2% | +$13.4K | 0.02% | 618 |
|
|
2017
Q4 | $586K | Sell |
10,865
-177
| -2% | -$9.55K | 0.02% | 624 |
|
|
2017
Q3 | $640K | Buy |
11,042
+1,829
| +20% | +$106K | 0.02% | 598 |
|
|
2017
Q2 | $455K | Hold |
9,213
| – | – | 0.01% | 652 |
|
|
2017
Q1 | $400K | Buy |
9,213
+4,768
| +107% | +$207K | 0.01% | 698 |
|
|
2016
Q4 | $218K | Buy |
+4,445
| New | +$218K | 0.01% | 817 |
|